Expert-reviewed insights on diabetes, GLP-1 therapies, and metabolic wellness — in English, Spanish, French, and Portuguese.
Explore Articles
From semaglutide to tirzepatide, GLP-1 receptor agonists have become the most talked-about class of drugs in modern medicine. We explore the science, the benefits, and what Canadians need to know.
Dr. Sarah Mitchell
With over 3.5 million Canadians living with diabetes, the need for innovative prevention and management strategies has never been greater.
Dr. James Okafor
Metabolic syndrome is a cluster of interconnected conditions that dramatically increases the risk of heart disease, stroke, and type 2 diabetes.
Dr. Émilie Tremblay
What you eat profoundly impacts insulin sensitivity. From the Mediterranean diet to time-restricted eating, we review the strongest evidence.
Dr. Anika Patel
Physical activity is one of the most powerful tools for blood sugar regulation. Discover the optimal exercise strategies backed by science.
Dr. Michael Chen
CGMs are no longer just for diabetes patients. A growing number of health-conscious Canadians are using these devices to optimize their metabolic health.
Dr. Laura Singh
With weight loss exceeding 24% in trials, retatrutide — targeting GLP-1, GIP, and glucagon receptors simultaneously — represents the next frontier in metabolic medicine.
Dr. James Okafor
For patients who dread weekly injections, oral semaglutide and next-generation GLP-1 pills promise a revolution in convenience. But do they work as well?
Dr. Sarah Mitchell
Healthy meal kits delivered. Low-glycemic recipes designed by Canadian dietitians.
Get Started